Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

165
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
165
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

473
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
473
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

616
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
616
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

732
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
732
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

1.4K
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
1.4K
Alterations in Blood Pressure01:30

Alterations in Blood Pressure

1.7K
Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Residual gastric content after holding of glucagon-like peptide-1 receptor agonists before elective surgery: a cross-sectional study - the RESIDUAL study.

BMC anesthesiology·2026
Same author

International practices and variability in right heart echocardiography: results from the RVNet(Work) international survey.

Echo research and practice·2026
Same author

Short-term physical compatibility of milrinone and epoprostenol for inhalation in cardiac surgery.

Canadian journal of anaesthesia = Journal canadien d'anesthesie·2026
Same author

Defining Perioperative Right Heart Failure in Cardiac Surgery: A Multiparametric Approach to Diagnosis and Management.

Anesthesiology·2026
Same author

A Pilot Randomized Controlled Trial of Ultrasound Evaluation of Fluid Tolerance for Acute Kidney Injury: USE-the-FORCE-for-AKI Trial.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Intra-Dialytic Hypotension and the VExUS Assessment in Hospitalized Patients: A Prospective Cohort Study.

Cardiorenal medicine·2026

Related Experiment Video

Updated: Dec 9, 2025

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance
14:09

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance

Published on: March 21, 2013

21.5K

Potential risks in using midodrine for persistent hypotension after cardiac surgery: a comparative cohort study.

Jan-Alexis Tremblay1, Philippe Laramée2, Yoan Lamarche3,4

  • 1Critical Care, Université de Montréal, 2900 Boulevard Edouard-Montpetit, Montréal, QC, H3T 1J4, Canada. janalexis.tremblay@gmail.com.

Annals of Intensive Care
|September 14, 2020
PubMed
Summary

Midodrine administration after cardiac surgery with cardiopulmonary bypass (CPB) was linked to worse outcomes, including fewer days free from the ICU and increased mortality. Caution is advised for its routine use in these patients.

Keywords:
Cardiac surgeryHypotensionMidodrineVasodilationVasoplegiaVasopressor

More Related Videos

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

538
Study of Experimental Organ Donation Models for Lung Transplantation
08:56

Study of Experimental Organ Donation Models for Lung Transplantation

Published on: March 15, 2024

1.9K

Related Experiment Videos

Last Updated: Dec 9, 2025

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance
14:09

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance

Published on: March 21, 2013

21.5K
Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

538
Study of Experimental Organ Donation Models for Lung Transplantation
08:56

Study of Experimental Organ Donation Models for Lung Transplantation

Published on: March 15, 2024

1.9K

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Pharmacology

Background:

  • Persistent hypotension is a common post-cardiac surgery complication.
  • Midodrine, an alpha-agonist, is considered for reducing vasopressor needs and accelerating ICU discharge.
  • This study investigated midodrine's impact on patients with post-cardiac surgery hypotension.

Purpose of the Study:

  • To explore the clinical effects of midodrine in patients experiencing persistent hypotension after cardiopulmonary bypass (CPB).
  • To test the hypothesis that midodrine accelerates ICU discharge and increases days free from ICU.

Main Methods:

  • Retrospective cohort study of patients receiving midodrine for hypotension post-CPB.
  • Propensity score matching created a control group of similar patients.
  • 74 matched pairs (1:1) were analyzed.

Main Results:

  • Midodrine use was associated with fewer days free from ICU (25.8 vs 27.2 days) and longer ICU stays (99 vs 68 hours).
  • Mortality was significantly higher in the midodrine group (13.5% vs 1.4%).
  • No significant differences were observed in vasopressor duration, ICU readmission rates, or severe kidney injury.

Conclusions:

  • Midodrine administration for hypotension post-CPB correlated with adverse outcomes, including reduced ICU-free days and increased mortality.
  • Routine use of midodrine to expedite ICU discharge after cardiac surgery warrants caution pending further investigation.